Ó£»¨ÊÓÆµ

Skip to main content

Table 3 Subgroup analysis of adjusted ORs with 95% CIs of high blood pressure incidence according to serum uric acid levels

From: Gender-specific association between serum uric acid levels and hypertension in East China: a cross-sectional study

Ìý

Q1

Q2

Q3

Q4

ÌýÌý

Variable

OR

OR, 95% CI

p Value

OR, 95% CI

p Value

OR, 95% CI

p Value

p Trend

p Interaction

Males

ÌýÌýÌýÌýÌýÌýÌýÌýÌý

Age, y

ÌýÌýÌýÌýÌýÌýÌýÌý

0.4244

 ≤ 50

1

1.02

0.8526

0.99

0.8644

1.11

0.2165

0.2431

Ìý

(0.87, 1.20)

(0.84, 1.16)

(0.94, 1.30)

 &²µ³Ù; 50

1

1.19

0.0902

1.18

0.1367

1.17

0.1934

0.1703

Ìý

(0.97, 1.45)

(0.95, 1.46)

(0.92, 1.48)

BMI, kg/m2

ÌýÌýÌýÌýÌýÌýÌýÌý

0.8677

 ≤ 25

1

1.18

0.0504

1.04

0.6981

1.29

0.0150*

0.0671

Ìý

(1.00, 1.40)

(0.86, 1.25)

(1.05, 1.58)

 &²µ³Ù; 25

1

1

0.9802

1.04

0.6382

1.08

0.4212

0.3206

Ìý

(0.83, 1.20)

(0.87, 1.25)

(0.90, 1.28)

Diabetes

ÌýÌýÌýÌýÌýÌýÌýÌý

0.0872

 Y±ð²õ

1

0.88

0.6832

1.18

0.5961

2.68

0.0099*

0.0304*

Ìý

(0.49, 1.60)

(0.64, 2.20)

(1.27, 5.68)

 N´Ç

1

1.1

0.1591

1.05

0.4674

1.15

0.0462*

0.0944

Ìý

(0.97, 1.24)

(0.92, 1.19)

(1.00, 1.31)

Female

ÌýÌýÌýÌýÌýÌýÌýÌýÌý

Age, y

ÌýÌýÌýÌýÌýÌýÌýÌý

0.321

 ≤ 50

1

0.94

0.6188

0.91

0.4563

0.96

0.7874

0.742

Ìý

(0.73, 1.21)

(0.71, 1.17)

(0.74, 1.26)

 &²µ³Ù; 50

1

1.3

0.1039

0.94

0.6776

0.94

0.7977

0.5519

Ìý

(0.95, 1.79)

(0.68, 1.29)

(0.68, 1.29)

BMI, kg/m2

ÌýÌýÌýÌýÌýÌýÌýÌý

0.1689

 ≤ 25

1

1.15

0.2154

0.94

0.6094

1.12

0.3344

0.7409

Ìý

(0.92, 1.43)

(0.75, 1.18)

(0.89, 1.42)

 &²µ³Ù; 25

1

0.86

0.5187

0.82

0.377

0.8

0.2946

0.3372

Ìý

(0.55, 1.36)

(0.54, 1.27)

(0.54, 1.21)

Diabetes

ÌýÌýÌýÌýÌýÌýÌýÌý

0.8582

 Y±ð²õ

1

1.68

0.486

0.47

0.3954

1.77

0.4042

0.6686

Ìý

(0.39, 7.23)

(0.08, 2.70)

(0.46, 6.74)

 N´Ç

1

1.08

0.4336

0.94 (0.77, 1.15)

0.5468

1.02

0.8618

0.7867

Ìý

(0.89, 1.32)

(0.83, 1.25)

  1. Notes: Serum uric acid quartiles (Q1–Q4) in men (Q1: ≤ 346.70; Q2: 346.70–395.30; Q3: 395.30–448.70; and Q4: > 448.70 µ mol/L). In women (Q1: ≤ 244.50; Q2: 244.50–281.10; Q3: 281.10–320.80; and Q4: > 320.80 µ mol/L). In total population (Q1: ≤ 278.30; Q2: 278.30–338.60; Q3: 338.60–407.20; and Q4: > 407.20 µ mol/L). BMI, body mass index; FBG, fasting blood glucose; eGFR, estimated glomerular filtration rate; TG, triglycerides; TC, total cholesterol; LDL, low density lipoprotein; HDL, high density lipoprotein
  2. Model: Adjusted for age, gender, BMI, FBG, diabetes, TG, TC, LDL, HDL, pulse and eGFR. Corresponding factors were not adjusted for each subgroup
  3. *±Ê-³Õ²¹±ô³Ü±ð &±ô³Ù; 0.05